Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study of Rizatriptan Co-Administered With Acetaminophen for the Treatment of Acute Migraine
This study has been completed.
Study NCT00300924   Information provided by Diamond Headache Clinic
First Received: March 9, 2006   Last Updated: May 27, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Migraine
Additional conditions recognized in this trial
Migraine Disorders
More general conditions related to this trial
Brain Diseases
Central Nervous System Diseases
Headache Disorders
Headache Disorders, Primary
Nervous System Diseases
Additional drug interventions recognized in this trial
Acetaminophen
Rizatriptan
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Central Nervous System Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Serotonin Agents
Serotonin Agonists
Therapeutic Uses
Sponsors listed in this trial
Diamond Headache Clinic
Merck


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services